← Every company
Supernus Pharmaceuticals Inc Lobbying
What Supernus Pharmaceuticals Inc discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
SUPN on carbonthat →Disclosed spend
$40K
across every filing on file
Filings
2
Years covered
1
Firms retained
1
What it lobbies about
Health IssuesMedicare/Medicaid
2 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20262nd Quarter (Apr 1 - June 30) | JEFFREY J. KIMBELL & ASSOCIATES, INC.Health IssuesMedicare/Medicaid | $20K |
| 20261st Quarter (Jan 1 - Mar 31) | JEFFREY J. KIMBELL & ASSOCIATES, INC.Health IssuesMedicare/Medicaid | $20K |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on SUPN
Company overviewEverything on SUPN in one place, with the price.SEC filingsWhat SUPN's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat SUPN's own officers and directors buy and sell.Executive payWhat SUPN awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in SUPN.Funds holding itWhich funds and ETFs hold SUPN, and how big a bet.Who lobbies for itThe lobbyists on SUPN's account, and who they worked for.PatentsWhat SUPN is filing at the patent office.